Scientists at IOCB Prague are developing a new generation of DNA tests for a wide range of applications
A research group led by Dr. Edward Curtis has developed two new types of catalytic DNA molecules (deoxyribozymes) that can reveal the presence of target molecules through fluorescence or color.
Thanks to his new discovery, Pavel Hobza stands a great chance at rewriting the textbooks of physical chemistry
Pavel Hobza from the IOCB Prague and his team discovered improper hydrogen bond twenty years ago. Current discovery has the potential to simplify the previously adopted definition of the hydrogen bond.
From a scientific project to a global business venture. The company mzio is striving to improve data analysis in mass spectrometry labs
A piece of software which enables researchers worldwide to speed up their work and helps them make scientific discoveries is expanding from science into commerce.
Cryo-EM structures show how Trypanosomes escape the human innate immune response
Researchers from IOCB Prague determined the first cryo-EM structures of a surface receptor of the human parasite T. brucei gambiense in complex with human complement factor C3 in different conformations.
IOCB Tech has opened Pharmtheon, a high-tech center for new medicines in Prague
State-of-the-art laboratories have found their home at Harfa in Prague, where preclinical research will be conducted to bring promising molecules closer to the development of important medications.
Material genetics will be pursued by the AMULET project, which succeeded in the Excellent Research Call
Scientists are combining zero-dimensional (quantum dots), one-dimensional (e.g. nanotubes), and two-dimensional (e.g. graphene) materials in the lab to give them new and unusual properties.
